D68.312 – Antiphospholipid antibody with hemorrhagic disorder
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Type 1 Excludes
antiphospholipid antibody, finding without diagnosis (R76.0)
antiphospholipid antibody syndrome (D68.61)
antiphospholipid antibody with hypercoagulable state (D68.61)
lupus anticoagulant (LAC) finding without diagnosis (R76.0)
lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
Applicable To
Lupus anticoagulant (LAC) with hemorrhagic disorder
Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
GEM Conversion to ICD-9 CM
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Antibody
with
with
with
with
with
Antiphospholipid
antibody
Lupus
with
erythematosus
(discoid) (local)
L93.0
with
Sibling Codes
Parent Sibling Codes
Codes with Same Suffix
View in Tabular
Code | Title |
---|---|
D50-D89 | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) |
D65-D69 | Coagulation defects, purpura and other hemorrhagic conditions (D65-D69) |
D68 | Other coagulation defects |
D68.3 | Hemorrhagic disorder due to circulating anticoagulants |
D68.31 | Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
D68.312 |
Antiphospholipid antibody with hemorrhagic disorder
Type 1 Excludes
antiphospholipid antibody, finding without diagnosis (R76.0)
antiphospholipid antibody syndrome (D68.61)
antiphospholipid antibody with hypercoagulable state (D68.61)
lupus anticoagulant (LAC) finding without diagnosis (R76.0)
lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
Applicable to
Lupus anticoagulant (LAC) with hemorrhagic disorder
Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
|